FFR and IFR: Are We Talking About the Same Thing?

To evaluate borderline coronary lesions (a 40% to 70% obstruction), determining associated ischemia is paramount. For this purpose, pressure gradients are measured across the stenosis. These measurements can be hyperemic, such as the fractional flow reserve (FFR), or taken at rest, such as the instantaneous wave-free ratio (iFR).

FFR e IFR ¿Hablamos de lo mismo?

According to the iFR-SWEDEHEART 5-year follow-up outcomes, both strategies have demonstrated effectiveness, as iFR is non-inferior to FFR. However, in different reports, these measurements have shown a correlation close to 80%. An altered reactivity of endothelial cells to vasoactive drugs might explain the observed discordance.

Whether this endothelial phenomenon can be caused by genetic polymorphisms of enzymes responsible for vasodilatation, such as endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1), is uncertain.

Building on this, the aim of this study was to analyze lesions and patients with discordant FFR and iFR measurements, and to determine whether polymorphism in the eNOS gene and in HO-1 influence coronary pressure and flow measurements.

Enrollment included patients with acute coronary syndrome (non-culprit vessel measurement) and chronic coronary syndromes in centers in the Czech Republic, Japan, and Argentina. FFR, IFR, and—in some cases—coronary flow reserve (CFR) were measured. Nitroglycerin 200 µg pre-measurement and adenosine 240 µg were systematically administered for pressure and flow measurements.

Read also: TAVR, More Information Supports Its Use.

Three groups of tests were classified according to positive or negative results: FFR/iFR concordance, FFRp/iFRn discordance, and FFRn/iFRp discordance.

A total of 1884 measurements from 1564 patients were analyzed; most measurements corresponded to the anterior descending artery (58%). FFR/iFR discordance was observed in 20.9% of the measurements, with FFRp/iFRn being the most frequent. In flow measurements, CFR correlated better with iFR (R = 0.56; p < 0.0001) than with FFR (R = 0.36; p <0.0001). When genetic analysis was conducted, eNOS and HO-1 polymorphisms showed no changes in FFR or IFR values.

Right coronary lesions presented a higher FFRp/iFRn index, which would indicate a distinctive coronary flow (absence of maximum flow in meso-diastole). In turn, this FFRp/iFRn discordance was observed in situations with indemnity of endothelial function, especially in young patients, and more frequently in men than in women.

Read also: Using Biolimus-Coated Balloons for Treating Small-Vessel Disease Yields Promising Results.

The FFRn/iFRp discordance presented increased microvascular resistance (decreased CFR). These were generally older patients who suffered more frequently from chronic kidney disease. This discordance was more commonly observed in patients with eNOS and HO-1 polymorphism.

Conclusions

There was a 21% discordance between FFR and iFR measurements. FFRn/iFRp discordance is probably caused by a defective endothelial reaction to vasodilator drugs. Additionally, eNOS and HO-1 gene polymorphisms were more frequently observed in this group.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.

Reference: Kovarnik, Tomas et al. “Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.” Journal of the American Heart Association vol. 11,9 (2022): e021490. doi:10.1161/JAHA.121.021490.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...